The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Subgroup analysis of patients enrolled in the United States in the CORRECT phase 3 trial of the multikinase inhibitor regorafenib (REG) in metastatic colorectal cancer (mCRC).
 
Heinz-Josef Lenz
Honoraria - Bayer
Consulting or Advisory Role - Bayer
Research Funding - Bayer
Travel, Accommodations, Expenses - Bayer
 
Eric Van Cutsem
Research Funding - Bayer (Inst)
 
Udit N. Verma
Consulting or Advisory Role - Bayer
Speakers' Bureau - Bayer
 
Marc Saltzman
Consulting or Advisory Role - Bayer
Speakers' Bureau - Archimedes
Research Funding - Bayer; Cubist; Hospira; Merck
 
Jyotsna Fuloria
No Relationships to Disclose
 
Ali Khojasteh
No Relationships to Disclose
 
Martin Wiesenfeld
No Relationships to Disclose
 
Frank Cihon
Employment - Bayer
Stock and Other Ownership Interests - Bayer
 
Andrea Wagner
Employment - Bayer
 
Axel Grothey
Consulting or Advisory Role - Bayer (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Lilly (Inst)
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Lilly (Inst)
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Genentech; Lilly